Inhibition of effector antigen-specific T cells by intradermal administration of heme oxygenase-1 inducers

Abstract Developing protocols aimed at inhibiting effector T cells would be key for the treatment of T cell-dependent autoimmune diseases including type 1 autoimmune diabetes (T1D) and multiple sclerosis (MS). While heme oxygenase-1 (HO-1) inducers are clinically approved drugs for non-immune-relate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of autoimmunity 2017-07, Vol.81, p.44-55
Hauptverfasser: Simon, Thomas, Pogu, Julien, Rémy, Séverine, Brau, Frédéric, Pogu, Sylvie, Maquigneau, Maud, Fonteneau, Jean-François, Poirier, Nicolas, Vanhove, Bernard, Blancho, Gilles, Piaggio, Eliane, Anegon, Ignacio, Blancou, Philippe
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!